Beijing Capital Securities gives Jiudian Pharmaceutical a buy rating: the performance is in line with expectations, and the loxoprofen sodium gel patch is in high-speed volume.

  • Post date April 29, 2022 — 12:26 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

300322 300705 Beijing Capital Huizhou Speed Wireless Technology Hunan Jiudian Pharmaceutical Research, Development Pharmaceutical Paper, Packaging Product Prices Securities Epidemic Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data